1613321-02-0Relevant articles and documents
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity
Anderson, Regan J.,Compton, Benjamin J.,Tang, Ching-Wen,Authier-Hall, Astrid,Hayman, Colin M.,Swinerd, Gene W.,Kowalczyk, Renata,Harris, Paul,Brimble, Margaret A.,Larsen, David S.,Gasser, Olivier,Weinkove, Robert,Hermans, Ian F.,Painter, Gavin F.
, p. 5120 - 5127 (2015/08/24)
It is known that T cells can eliminate tumour cells through recognition of unique or aberrantly expressed antigens presented as peptide epitopes by major histocompatibility complex (MHC) molecules on the tumour cell surface. With recent advances in defini
CONJUGATE COMPOUNDS
-
, (2014/06/24)
The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.